ArticleClinical case reports2025
First Case of Primary Breast Melanoma in Central America: Case Report and Literature Review.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review.Frontiers in oncology · 2026Article
- First Case of Primary Breast Melanoma in Central America: Case Report and Literature Review.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary breast melanoma is an exceedingly rare neoplasm, accounting for < 0.5% of all malignant breast tumors. Its scarcity and highly variable clinical presentation often delay diagnosis and complicate management. We report the case of a 55-year-old woman with a primary non-cutaneous melanoma of the right breast initially misdiagnosed as high-grade ductal carcinoma. As a result of discordant biopsy results, the lesion progressed developing ulceration, tissue destruction, and axillary metastases. Definitive diagnosis was established via repeated incisional biopsies and immunohistochemistry. Management comprised neoadjuvant dacarbazine (discontinued owing to toxicity and disease progression), modified radical mastectomy, delayed split-thickness skin graft, targeted antibiotic therapy for a carbapenemase-producing infection, adjuvant carboplatin-paclitaxel, and locoregional radiotherapy. Twelve months later, right-side inguinal nodal metastases were resected and irradiated. At 18-month follow-up, the patient remains disease-free. This case underscores the diagnostic and therapeutic challenges of primary breast melanoma and highlights the importance of early multidisciplinary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.